These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Ciancio G, Burke GW, Gaynor JJ, Mattiazzi A, Roth D, Kupin W, Nicolas M, Ruiz P, Rosen A, Miller J. Transplantation; 2004 Jan 27; 77(2):244-51. PubMed ID: 14742989 [Abstract] [Full Text] [Related]
6. Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen. Greanya ED, Poulin E, Partovi N, Shapiro RJ, Al-Khatib M, Ensom MH. Am J Health Syst Pharm; 2012 Jan 15; 69(2):134-42. PubMed ID: 22215359 [Abstract] [Full Text] [Related]
7. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation. Mardigyan V, Tchervenkov J, Metrakos P, Barkun J, Deschenes M, Cantarovich M. Clin Ther; 2005 Apr 15; 27(4):463-9. PubMed ID: 15922819 [Abstract] [Full Text] [Related]
9. Survival Associated With Sirolimus Plus Tacrolimus Maintenance Without Induction Therapy Compared With Standard Immunosuppression After Lung Transplant. Wijesinha M, Hirshon JM, Terrin M, Magder L, Brown C, Stafford K, Iacono A. JAMA Netw Open; 2019 Aug 02; 2(8):e1910297. PubMed ID: 31461151 [Abstract] [Full Text] [Related]
10. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients. Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y. Clin Pharmacokinet; 2004 Aug 02; 43(11):741-62. PubMed ID: 15301578 [Abstract] [Full Text] [Related]
11. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant. Pawinski T, Durlik M, Szlaska I, Urbanowicz A, Majchrnak J, Gralak B. J Clin Pharm Ther; 2006 Feb 02; 31(1):27-34. PubMed ID: 16476117 [Abstract] [Full Text] [Related]
20. Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry. Doria C, Greenstein S, Narayanan M, Ueda K, Wiland A, McCague K, Sankari B, Chan L. Clin Transplant; 2012 Mar 05; 26(6):E602-11. PubMed ID: 23121178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]